Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 53738-53740 [2018-23231]

Download as PDF 53738 Federal Register / Vol. 83, No. 206 / Wednesday, October 24, 2018 / Notices experience, and medical condition of each applicant were stated and discussed in detail in the August 15, 2018, Federal Register notice (83 FR 40642) and will not be repeated in this notice. These 39 applicants have had ITDM over a range of 1 to 59 years. These applicants report no severe hypoglycemic reactions resulting in loss of consciousness or seizure, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning symptoms, in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the past five years. In each case, an endocrinologist verified that the driver has demonstrated a willingness to properly monitor and manage his/her diabetes mellitus, received education related to diabetes management, and is on a stable insulin regimen. These drivers report no other disqualifying conditions, including diabetes related complications. Each meets the vision requirement at 49 CFR 391.41(b)(10). Consequently, FMCSA finds that in each case exempting these applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is likely to achieve a level of safety equal to that existing without the exemption. amozie on DSK3GDR082PROD with NOTICES1 V. Conditions and Requirements The terms and conditions of the exemption are provided to the applicants in the exemption document and includes the following: (1) Each driver must submit a quarterly monitoring checklist completed by the treating endocrinologist as well as an annual checklist with a comprehensive medical evaluation; (2) each driver must report within two business days of occurrence, all episodes of severe hypoglycemia, significant complications, or inability to manage diabetes; also, any involvement in an accident or any other adverse event in a CMV or personal vehicle, whether or not it is related to an episode of hypoglycemia; (3) each driver must provide a copy of the ophthalmologist’s or optometrist’s report to the Medical Examiner at the time of the annual medical examination; and (4) each driver must provide a copy of the annual medical certification to the employer for retention in the driver’s qualification file, or keeping a copy in his/her driver’s qualification file if he/ she is self-employed. The driver must also have a copy of the exemption when driving, for presentation to a duly authorized Federal, State, or local enforcement official. VerDate Sep<11>2014 17:43 Oct 23, 2018 Jkt 247001 VI. Preemption During the period the exemption is in effect, no State shall enforce any law or regulation that conflicts with this exemption with respect to a person operating under the exemption. VII. Conclusion Frm 00135 Fmt 4703 [FR Doc. 2018–23230 Filed 10–23–18; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Based upon its evaluation of the 39 exemption applications, FMCSA exempts the following drivers from the diabetes requirement in 49 CFR 391.41(b)(10), subject to the requirements cited above: Jeffrey L. Barton (KS) Michael J. Beattie (TN) Timothy W. Beeny (KY) Joseph A. Bradley (IN) Harold B. Bryan (ID) Javis B. Cruz (NM) Matthew A. Cunningham (NY) Victor J. Da-Chao (MD) Timothy S. Danley (TX) Richard G. Dattler, Jr. (OR) Ellen M. Diggs (KS) Marven J. Finken (MN) Randie S. Fisher, Jr. (MO) Jason J. Fleisch (PA) Ryan M. Galusha (NY) Raymond M. Hamlin (ME) Steven L. Hare, Jr. (NC) Joshua R. Hedges (MO) Vicky L. Hill (WA) Charles O. Hudson (TN) James A. Keebaugh (PA) Rein R. Kori (TN) Thomas C. McGee (SC) Anton Means (IL) Andrew P. Metze (SC) Christopher J. Misner (MI) Mohamed S. Mohamed (MA) Eugene G. Mueller (WI) Reginald J. Pokorny (NE) Vernon C. Read (CA) John W. Rosenthal (ID) Steven A. Santamaria (IL) Ricky J. Sawyer (AL) Justin G. Simpson (OH) Jacob H. Turner (AR) Chad E. Vanscoy (OH) Phillip M. Woods (MI) Robert W. Youdath (OH) Brian D. Zoll (OH) In accordance with 49 U.S.C. 31136(e) and 31315, each exemption will be valid for two years from the effective date unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained prior to being granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136(e) and 31315. PO 00000 Issued on: October 15, 2018. Larry W. Minor, Associate Administrator for Policy. Sfmt 4703 Federal Motor Carrier Safety Administration [FMCSA Docket No. FMCSA–2018–0032] Qualification of Drivers; Exemption Applications; Diabetes Mellitus Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of final disposition. AGENCY: FMCSA announces its decision to exempt 54 individuals from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with insulin-treated diabetes mellitus (ITDM) from operating a commercial motor vehicle (CMV) in interstate commerce. The exemptions enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: The exemptions were applicable on August 17, 2018. The exemptions expire on August 17, 2020. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64–224, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366–9826. SUPPLEMENTARY INFORMATION: SUMMARY: I. Public Participation A. Viewing Documents and Comments To view comments, as well as any documents mentioned in this notice as being available in the docket, go to http://www.regulations.gov. Insert the docket number, FMCSA–2018–0032, in the keyword box, and click ‘‘Search.’’ Next, click the ‘‘Open Docket Folder’’ button and choose the document to review. If you do not have access to the internet, you may view the docket online by visiting the Docket Management Facility in Room W12–140 on the Ground Floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. E:\FR\FM\24OCN1.SGM 24OCN1 Federal Register / Vol. 83, No. 206 / Wednesday, October 24, 2018 / Notices B. Privacy Act In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL– 14 FDMS), which can be reviewed at www.dot.gov/privacy. II. Background On July 17, 2018, FMCSA published a notice announcing receipt of applications from 53 individuals requesting an exemption from the insulin-treated diabetes mellitus prohibition in 49 CFR 391.41(b)(3), to operate a CMV in interstate commerce and requested comments from the public (83 FR 27070). The public comment period ended on August 16, 2018, and one comment was received. FMCSA has evaluated the eligibility of these applicants and determined that granting the exemptions to these individuals would achieve a level of safety equivalent to or greater than the level that would be achieved by complying with the current regulation 49 CFR 391.41(b)(3). The physical qualification standard for drivers regarding diabetes found in 49 CFR 391.41(b)(3) states that a person is physically qualified to drive a CMV if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control. amozie on DSK3GDR082PROD with NOTICES1 III. Discussion of Comments FMCSA received one comment in this proceeding. Alexandra Reese from the state of Minnesota stated that the state of Minnesota has no objections to granting diabetes exemptions to Benjamin J. Boeding and Thomas W. Markham. IV. Basis for Exemption Determination Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption for up to five years from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is likely to achieve an equivalent or greater level of safety than would be achieved without the exemption. The exemption allows the applicants to operate CMVs in interstate commerce. FMCSA grants exemptions from the FMCSRs for a two-year period to align with the maximum duration of a driver’s medical certification. The Agency’s decision regarding these exemption applications is based on the program eligibility criteria and an individualized assessment of information submitted by each VerDate Sep<11>2014 17:43 Oct 23, 2018 Jkt 247001 applicant. The qualifications, experience, and medical condition of each applicant were stated and discussed in detail in the July 17, 2018, Federal Register notice (83 FR 33297) and will not be repeated in this notice. These 54 applicants have had ITDM over a range of 1 to 46 years. These applicants report no severe hypoglycemic reactions resulting in loss of consciousness or seizure, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning symptoms, in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the past five years. In each case, an endocrinologist verified that the driver has demonstrated a willingness to properly monitor and manage his/her diabetes mellitus, received education related to diabetes management, and is on a stable insulin regimen. These drivers report no other disqualifying conditions, including diabetes related complications. Each meets the vision requirement at 49 CFR 391.41(b)(10). Consequently, FMCSA finds that in each case exempting these applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is likely to achieve a level of safety equal to that existing without the exemption. V. Conditions and Requirements The terms and conditions of the exemption are provided to the applicants in the exemption document and includes the following: (1) Each driver must submit a quarterly monitoring checklist completed by the treating endocrinologist as well as an annual checklist with a comprehensive medical evaluation; (2) each driver must report within two business days of occurrence, all episodes of severe hypoglycemia, significant complications, or inability to manage diabetes; also, any involvement in an accident or any other adverse event in a CMV or personal vehicle, whether or not it is related to an episode of hypoglycemia; (3) each driver must provide a copy of the ophthalmologist’s or optometrist’s report to the Medical Examiner at the time of the annual medical examination; and (4) each driver must provide a copy of the annual medical certification to the employer for retention in the driver’s qualification file, or keeping a copy in his/her driver’s qualification file if he/ she is self-employed. The driver must also have a copy of the exemption when driving, for presentation to a duly authorized Federal, State, or local enforcement official. PO 00000 Frm 00136 Fmt 4703 Sfmt 4703 53739 VI. Preemption During the period the exemption is in effect, no State shall enforce any law or regulation that conflicts with this exemption with respect to a person operating under the exemption. VII. Conclusion Based upon its evaluation of the 53 exemption applications, FMCSA exempts the following drivers from the rule prohibiting drivers with ITBM from driving CMV’s in interstate commerce in 49 CFR 391.41(b)(10), subject to the requirements cited above: David V. Amado (CA) Allan D. Arcand (WI) Nickie D. Archuleta (PA) Mathew B. Bartlett (IA) Sean S. Bateman (NY) Marvin E. Battle, Jr. (GA) Gordon R. Bayles (UT) Kirk W. Behrer (PA) Benjamin J. Boeding (MN) Robert A. Bowman (KY) Michael G. Cohen (NY) John R. Delucca (IN) James M. Dubay (MI) Larry I. Frizell (IA) Gerson A. Gonzalez (NJ) David D. Gross (PA) Ricky A. Kirby (KY) Dustin M. Kirkland (OH) Scott M. Kiser (GA) Lee E. Koehn (AL) Wayne L. Kracht (IA) Jeffrey L. Kramer (OH) Brad M. Ligols (MA) Kenneth J. Lubanski (NJ) Thomas W. Markham (MN) Richard T. McAtee II (OH) John T. McEntire III (SC) Jonathan D. Miles (IN) Brian J. Morgan (VT) Cecil M. Morris, Jr. (KY) Nicholas C. O’Connor (MA) Rowdy V. Orr (TX) Neal J. Pangrazio (NY) William T. Phipps, Jr. (MD) Robert A. Pope (IA) Micky J. Powers (MI) Shawn K. Richardson (WA) Joselito Rosario (MA) Gregory L. Ryan (DE) Howard G. Schrepp (GA) James W. Shirk (PA) Michael J. Simko (PA) Roderick Q. Smith (IL) Walter C. Snoodgrass, Jr. (IN) Robert W. Stewart (NC) Joseph W. Symons (MI) Felipe D. Torres (TX) James J. Triplett (TN) Amos L. Trujillo (NM) Lynda D. Vance (TN) Christopher E. Vazquez (CT) Michael J. Vigna (IL) Brian P. Walsh (IA) E:\FR\FM\24OCN1.SGM 24OCN1 53740 Federal Register / Vol. 83, No. 206 / Wednesday, October 24, 2018 / Notices Nathan L. Watson (TX) In accordance with 49 U.S.C. 31136(e) and 31315, each exemption will be valid for two years from the effective date unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained prior to being granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136(e) and 31315. Issued on: October 15, 2018. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2018–23231 Filed 10–23–18; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA–2018–0206] Qualification of Drivers; Exemption Applications; Diabetes Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of denials. AGENCY: FMCSA announces its decision to deny applications from seven individuals who requested an exemption from the Federal Motor Carrier Safety Regulations (FMCSRs) prohibiting persons with insulin-treated diabetes mellitus (ITDM) from operating a commercial motor vehicle (CMV) in interstate commerce. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64–224, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366–9826. SUPPLEMENTARY INFORMATION: amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:43 Oct 23, 2018 Jkt 247001 I. Public Participation A. Viewing Documents and Comments To view comments, as well as any documents mentioned in this notice as being available in the docket, go to http://www.regulations.gov. Insert the docket number, FMCSA–2018–0206, in the keyword box, and click ‘‘Search.’’ Next, click the ‘‘Open Docket Folder’’ button and choose the document to review. If you do not have access to the internet, you may view the docket online by visiting the Docket Management Facility in Room W12–140 on the ground floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. B. Privacy Act In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL– 14 FDMS), which can be reviewed at www.dot.gov/privacy. II. Background FMCSA received applications from seven individuals who requested an exemption from the FMCSRs prohibiting persons with ITDM from operating a CMV in interstate commerce. FMCSA has evaluated the eligibility of these applicants and concluded that granting these exemptions would not provide a level of safety that would be equivalent to or greater than, the level of safety that would be obtained by complying with the regulation 49 CFR 391.41(b)(3). III. Basis for Exemption Determination Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption if it finds such an exemption would likely achieve a level of safety that is equivalent to, or greater than, the level that would be achieved absent such an exemption. The Agency’s decision regarding these exemption applications is based on the PO 00000 Frm 00137 Fmt 4703 Sfmt 9990 eligibility criteria, the terms and conditions for Federal exemptions, and an individualized assessment of each applicant’s medical information provided by the applicant. IV. Conclusion The Agency has determined that these applicants do not satisfy the criteria eligibility or meet the terms and conditions of the Federal exemption and granting these exemptions would not provide a level of safety that would be equivalent to or greater than, the level of safety that would be obtained by complying with the regulation 49 CFR 391.41(b)(3). Therefore, the seven applicants in this notice have been denied exemptions from the physical qualification standards in 49 CFR 391.41(b)(3). Each applicant has, prior to this notice, received a letter of final disposition regarding his/her exemption request. Those decision letters fully outlined the basis for the denial and constitutes final action by the Agency. This notice summarizes the Agency’s recent denials as required under 49 U.S.C. 31315(b)(4) by periodically publishing names and reasons for denial. The following four applicants met the diabetes requirements of 49 CFR 391.41(b)(3) and do not need an exemption: Randal B. Bivin (TX) Joel D. Dillahunty (TX) Donald D. Gueiss (NC) Kurt A. Taranto (NY) The following two applicants had other medical conditions making the applicant otherwise unqualified under the Federal Motor Carrier Safety Regulations Norman C. Hutchinson, (IA); Curtis D. Lansdell, (AR). The following applicant, David L. Fisher (PA), did not have endocrinologists willing to make statements that he is able to operate CMVs from a diabetes standpoint. Issued on: October 15, 2018. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2018–23226 Filed 10–23–18; 8:45 am] BILLING CODE 4910–EX–P E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 83, Number 206 (Wednesday, October 24, 2018)]
[Notices]
[Pages 53738-53740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23231]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[FMCSA Docket No. FMCSA-2018-0032]


Qualification of Drivers; Exemption Applications; Diabetes 
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to exempt 54 individuals from the 
prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) 
against persons with insulin-treated diabetes mellitus (ITDM) from 
operating a commercial motor vehicle (CMV) in interstate commerce. The 
exemptions enable these individuals with ITDM to operate CMVs in 
interstate commerce.

DATES: The exemptions were applicable on August 17, 2018. The 
exemptions expire on August 17, 2020.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Programs Division, (202) 366-4001, [email protected], FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., 
ET, Monday through Friday, except Federal holidays. If you have 
questions regarding viewing or submitting material to the docket, 
contact Docket Services, telephone (202) 366-9826.

SUPPLEMENTARY INFORMATION: 

I. Public Participation

A. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice 
as being available in the docket, go to http://www.regulations.gov. 
Insert the docket number, FMCSA-2018-0032, in the keyword box, and 
click ``Search.'' Next, click the ``Open Docket Folder'' button and 
choose the document to review. If you do not have access to the 
internet, you may view the docket online by visiting the Docket 
Management Facility in Room W12-140 on the Ground Floor of the DOT West 
Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 
a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays.

[[Page 53739]]

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the 
public to better inform its rulemaking process. DOT posts these 
comments, without edit, including any personal information the 
commenter provides, to www.regulations.gov, as described in the system 
of records notice (DOT/ALL-14 FDMS), which can be reviewed at 
www.dot.gov/privacy.

II. Background

    On July 17, 2018, FMCSA published a notice announcing receipt of 
applications from 53 individuals requesting an exemption from the 
insulin-treated diabetes mellitus prohibition in 49 CFR 391.41(b)(3), 
to operate a CMV in interstate commerce and requested comments from the 
public (83 FR 27070). The public comment period ended on August 16, 
2018, and one comment was received.
    FMCSA has evaluated the eligibility of these applicants and 
determined that granting the exemptions to these individuals would 
achieve a level of safety equivalent to or greater than the level that 
would be achieved by complying with the current regulation 49 CFR 
391.41(b)(3).
    The physical qualification standard for drivers regarding diabetes 
found in
    49 CFR 391.41(b)(3) states that a person is physically qualified to 
drive a CMV if that person has no established medical history or 
clinical diagnosis of diabetes mellitus currently requiring insulin for 
control.

III. Discussion of Comments

    FMCSA received one comment in this proceeding. Alexandra Reese from 
the state of Minnesota stated that the state of Minnesota has no 
objections to granting diabetes exemptions to Benjamin J. Boeding and 
Thomas W. Markham.

IV. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption 
for up to five years from the diabetes standard in 49 CFR 391.41(b)(3) 
if the exemption is likely to achieve an equivalent or greater level of 
safety than would be achieved without the exemption. The exemption 
allows the applicants to operate CMVs in interstate commerce. FMCSA 
grants exemptions from the FMCSRs for a two-year period to align with 
the maximum duration of a driver's medical certification.
    The Agency's decision regarding these exemption applications is 
based on the program eligibility criteria and an individualized 
assessment of information submitted by each applicant. The 
qualifications, experience, and medical condition of each applicant 
were stated and discussed in detail in the July 17, 2018, Federal 
Register notice (83 FR 33297) and will not be repeated in this notice.
    These 54 applicants have had ITDM over a range of 1 to 46 years. 
These applicants report no severe hypoglycemic reactions resulting in 
loss of consciousness or seizure, requiring the assistance of another 
person, or resulting in impaired cognitive function that occurred 
without warning symptoms, in the past 12 months and no recurrent (two 
or more) severe hypoglycemic episodes in the past five years. In each 
case, an endocrinologist verified that the driver has demonstrated a 
willingness to properly monitor and manage his/her diabetes mellitus, 
received education related to diabetes management, and is on a stable 
insulin regimen. These drivers report no other disqualifying 
conditions, including diabetes related complications. Each meets the 
vision requirement at 49 CFR 391.41(b)(10).
    Consequently, FMCSA finds that in each case exempting these 
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is 
likely to achieve a level of safety equal to that existing without the 
exemption.

V. Conditions and Requirements

    The terms and conditions of the exemption are provided to the 
applicants in the exemption document and includes the following: (1) 
Each driver must submit a quarterly monitoring checklist completed by 
the treating endocrinologist as well as an annual checklist with a 
comprehensive medical evaluation; (2) each driver must report within 
two business days of occurrence, all episodes of severe hypoglycemia, 
significant complications, or inability to manage diabetes; also, any 
involvement in an accident or any other adverse event in a CMV or 
personal vehicle, whether or not it is related to an episode of 
hypoglycemia; (3) each driver must provide a copy of the 
ophthalmologist's or optometrist's report to the Medical Examiner at 
the time of the annual medical examination; and (4) each driver must 
provide a copy of the annual medical certification to the employer for 
retention in the driver's qualification file, or keeping a copy in his/
her driver's qualification file if he/she is self-employed. The driver 
must also have a copy of the exemption when driving, for presentation 
to a duly authorized Federal, State, or local enforcement official.

VI. Preemption

    During the period the exemption is in effect, no State shall 
enforce any law or regulation that conflicts with this exemption with 
respect to a person operating under the exemption.

VII. Conclusion

    Based upon its evaluation of the 53 exemption applications, FMCSA 
exempts the following drivers from the rule prohibiting drivers with 
ITBM from driving CMV's in interstate commerce in 49 CFR 391.41(b)(10), 
subject to the requirements cited above:

David V. Amado (CA)
Allan D. Arcand (WI)
Nickie D. Archuleta (PA)
Mathew B. Bartlett (IA)
Sean S. Bateman (NY)
Marvin E. Battle, Jr. (GA)
Gordon R. Bayles (UT)
Kirk W. Behrer (PA)
Benjamin J. Boeding (MN)
Robert A. Bowman (KY)
Michael G. Cohen (NY)
John R. Delucca (IN)
James M. Dubay (MI)
Larry I. Frizell (IA)
Gerson A. Gonzalez (NJ)
David D. Gross (PA)
Ricky A. Kirby (KY)
Dustin M. Kirkland (OH)
Scott M. Kiser (GA)
Lee E. Koehn (AL)
Wayne L. Kracht (IA)
Jeffrey L. Kramer (OH)
Brad M. Ligols (MA)
Kenneth J. Lubanski (NJ)
Thomas W. Markham (MN)
Richard T. McAtee II (OH)
John T. McEntire III (SC)
Jonathan D. Miles (IN)
Brian J. Morgan (VT)
Cecil M. Morris, Jr. (KY)
Nicholas C. O'Connor (MA)
Rowdy V. Orr (TX)
Neal J. Pangrazio (NY)
William T. Phipps, Jr. (MD)
Robert A. Pope (IA)
Micky J. Powers (MI)
Shawn K. Richardson (WA)
Joselito Rosario (MA)
Gregory L. Ryan (DE)
Howard G. Schrepp (GA)
James W. Shirk (PA)
Michael J. Simko (PA)
Roderick Q. Smith (IL)
Walter C. Snoodgrass, Jr. (IN)
Robert W. Stewart (NC)
Joseph W. Symons (MI)
Felipe D. Torres (TX)
James J. Triplett (TN)
Amos L. Trujillo (NM)
Lynda D. Vance (TN)
Christopher E. Vazquez (CT)
Michael J. Vigna (IL)
Brian P. Walsh (IA)

[[Page 53740]]

Nathan L. Watson (TX)

    In accordance with 49 U.S.C. 31136(e) and 31315, each exemption 
will be valid for two years from the effective date unless revoked 
earlier by FMCSA. The exemption will be revoked if the following 
occurs: (1) The person fails to comply with the terms and conditions of 
the exemption; (2) the exemption has resulted in a lower level of 
safety than was maintained prior to being granted; or (3) continuation 
of the exemption would not be consistent with the goals and objectives 
of 49 U.S.C. 31136(e) and 31315.

    Issued on: October 15, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-23231 Filed 10-23-18; 8:45 am]
 BILLING CODE 4910-EX-P